Should I buy or sell Neighbourly Pharmacy stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares. View NBLY analyst ratings or view top-rated stocks .

What is Neighbourly Pharmacy's stock price target for 2024?

6 brokers have issued 12-month target prices for Neighbourly Pharmacy's stock. Their NBLY share price targets range from C$20.00 to C$28.00. On average, they anticipate the company's share price to reach C$23.07 in the next twelve months. This suggests a possible upside of 30.9% from the stock's current price. View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts .

How have NBLY shares performed in 2023?

Neighbourly Pharmacy's stock was trading at C$23.39 at the beginning of 2023. Since then, NBLY stock has decreased by 24.6% and is now trading at C$17.63. View the best growth stocks for 2023 here .

How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?

Neighbourly Pharmacy announced a quarterly dividend on Monday, November 20th. Investors of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Monday, November 20th. Read our dividend analysis for NBLY .

Is Neighbourly Pharmacy a good dividend stock?

Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.01%. Read our dividend analysis for NBLY .

How do I buy shares of Neighbourly Pharmacy?

Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

Neighbourly Pharmacy Stock Price, News & Analysis (TSE:NBLY)

C$17.63

-0.25 (-1.40%)

(As of 12/4/2023 ET)

Compare

Today's Range: C$17.55
▼
C$17.87
50-Day Range: C$12.12
▼
C$19.09
52-Week Range: C$12.05
▼
C$25.50

Volume: 31,524 shs
Average Volume: 55,164 shs
Market Capitalization: C$789.82 million

P/E Ratio: N/A
Dividend Yield: 1.02%
Price Target: C$23.07

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines

About Neighbourly Pharmacy Stock (TSE:NBLY)

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

NBLY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NBLY Stock News Headlines

November 15, 2023 | msn.com

Down 20% in 8 Months, Is Neighbourly Pharmacy Stock a Buy Today?

November 13, 2023 | marketwatch.com

Neighbourly Pharmacy Shares Pull Back After Exclusivity Period With Suitor Extended

December 5, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 13, 2023 | finance.yahoo.com

Neighbourly Extends Exclusivity and Provides Update on Letter of Intent with Persistence Capital Partners

October 24, 2023 | finance.yahoo.com

Neighbourly Announces Strong Second Quarter Results

October 18, 2023 | finance.yahoo.com

An Intrinsic Calculation For Neighbourly Pharmacy Inc. (TSE:NBLY) Suggests It's 22% Undervalued

October 10, 2023 | finance.yahoo.com

Neighbourly Announces Timing of Second Quarter 2024 Earnings Release

October 4, 2023 | markets.businessinsider.com

BMO Capital Keeps a Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)

December 5, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

October 3, 2023 | theglobeandmail.com

Neighbourly Pharmacy agrees to go-private offer from private-equity backer

October 3, 2023 | msn.com

Neighbourly Pharmacy Stock (TSE:NBLY) to Be Acquired; Stock Soars 60%

October 3, 2023 | marketwatch.com

Neighbourly Pharmacy Shares Jump 57% on Go-Private Agreement With Private Equity Firm

October 3, 2023 | theglobeandmail.com

Neighbourly Pharmacy signs deal with largest shareholder to go private

October 3, 2023 | finance.yahoo.com

Neighbourly Enters into Letter of Intent to go Private with its Controlling Shareholder Persistence Capital Partners

October 2, 2023 | msn.com

2 Defensive Stocks That Can Gain up to 128%, According to Bay Street

September 29, 2023 | finance.yahoo.com

Neighbourly Recognized as One of Canada's Top Growing Companies in the Globe and Mail's Fifth-Annual Ranking

September 8, 2023 | finance.yahoo.com

While individual investors own 27% of Neighbourly Pharmacy Inc. (TSE:NBLY), private equity firms are its largest shareholders with 50% ownership

September 3, 2023 | ca.finance.yahoo.com

2 Stocks That Could Beat a Bear Market

August 25, 2023 | theglobeandmail.com

Closing Bell: Neighbourly Pharmacy Inc flat on Thursday (NBLY)

August 5, 2023 | finance.yahoo.com

Neighbourly Pharmacy (TSE:NBLY) Has Announced A Dividend Of CA$0.045

August 3, 2023 | markets.businessinsider.com

RBC Capital Maintains a Buy Rating on Neighbourly Pharmacy, Inc. (NBLY)

August 2, 2023 | markets.businessinsider.com

BMO Capital Keeps Their Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)

August 2, 2023 | finance.yahoo.com

Neighbourly Announces Annual Meeting Results

August 1, 2023 | finance.yahoo.com

Neighbourly Announces Strong First Quarter Results

July 25, 2023 | finance.yahoo.com

Neighbourly Pharmacy Inc. (TSE:NBLY) Is About To Turn The Corner

July 21, 2023 | finance.yahoo.com

NBLY.TO - Neighbourly Pharmacy Inc.

July 13, 2023 | markets.businessinsider.com

RBC Capital Remains a Buy on Neighbourly Pharmacy, Inc. (NBLY)

See More Headlines

Receive NBLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/26 Dividend: 8/28/2023
Dividend Payable: 9/26/2023
Ex-Dividend for 12/19 Dividend: 11/20/2023
Today: 12/04/2023
Dividend Payable: 12/19/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Pharmaceutical Retailers
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:NBLY
CUSIP: N/A
CIK: N/A
Web: neighbourlypharmacy.ca
Phone: 416 309 9102
Fax: N/A
Employees: 3,648
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$23.07
High Stock Price Target: C$28.00
Low Stock Price Target: C$20.00
Potential Upside/Downside: +30.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.85)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 25.03
P/E Growth: N/A
Net Income: C$-26,610,000.00
Net Margins: -3.20%
Pretax Margin: N/A
Return on Equity: -5.46%
Return on Assets: 0.94%

Debt

Debt-to-Equity Ratio: 56.99
Current Ratio: 1.15
Quick Ratio: 0.75

Sales & Book Value

Annual Sales: C$831.61 million
Price / Sales: 0.95
Cash Flow: C$0.57 per share
Price / Cash Flow: 31.16
Book Value: C$13.19 per share
Price / Book: 1.34

Miscellaneous

Outstanding Shares: 44,800,000
Free Float: N/A
Market Cap: C$789.82 million
Optionable: Not Optionable
Beta: 0.35

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Skip Bourdo (Age 46)
CEO & Director
Comp: $604.17k
Mr. Billy Wong C.M.A.
CPA, M.B.A., Chief Financial Officer
Mr. Jari Pekka Villanen (Age 52)
Senior Vice President of Operations
Comp: $307.48k
Mr. Roy J. Wieschkowski (Age 60)
Senior Vice President of People & Culture
Comp: $255.84k
Mr. Steve Losty (Age 49)
Chief Development Officer
Comp: $302.15k

Key Competitors

View All Competitors

Insiders

NBLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Neighbourly Pharmacy stock right now?: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares.
View NBLY analyst ratings or view top-rated stocks.
What is Neighbourly Pharmacy's stock price target for 2024?: 6 brokers have issued 12-month target prices for Neighbourly Pharmacy's stock. Their NBLY share price targets range from C$20.00 to C$28.00. On average, they anticipate the company's share price to reach C$23.07 in the next twelve months. This suggests a possible upside of 30.9% from the stock's current price.
View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts.
How have NBLY shares performed in 2023?: Neighbourly Pharmacy's stock was trading at C$23.39 at the beginning of 2023. Since then, NBLY stock has decreased by 24.6% and is now trading at C$17.63.
View the best growth stocks for 2023 here.
How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?: Neighbourly Pharmacy announced a quarterly dividend on Monday, November 20th. Investors of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Monday, November 20th.
Read our dividend analysis for NBLY.

Is Neighbourly Pharmacy a good dividend stock?: Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.01%.
Read our dividend analysis for NBLY.
How do I buy shares of Neighbourly Pharmacy?: Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NBLY) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial